Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, John M. Kane, MD, and Rebecca S. Roma, MD, discuss clinical assessment of extrapyramidal symptoms (EPS), antiparkinsonian drugs, and tardive dyskinesia (TD). They review differentiating between TD and EPS, identify tools for diagnosing TD, and provide some important clinical pearls and evidence-based reasons for choosing different medications for treating EPS and TD.
John M. Kane, MD
Professor and Chairman
Department of Psychiatry
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Glen Oaks, New York
Rebecca S. Roma, MD
Greg Mattingly, MD, and Manish Jha, MD, review the latest available clinical data for emerging therapy options for tardive dyskinesia, from Clinical Care Options (CCO)
Clinical Care Options (CCO) commentary by Thomas L. Schwartz, MD, on choosing the right atypical antipsychotic in bipolar I and bipolar II patients
Attention deficits in a bipolar patient with a history of cannabis use from Clinical Care Options (CCO)
Slides from a presentation that educates clinicians on innovations in managing essential tremor and dystonias.